News

The clinical review of the MVA-SARS-2-S vector vaccine against COVID-19 will continue with a new version. The DZIF (German Center for Infection Research) scientists temporarily suspended the study

To advance anti-tuberculosis (TB) science and enable the progression of new, safe, and affordable treatment solutions for TB patients worldwide, a new consortium of 30 partners from 13 countries has

The molecular biologist Prof. Stefan Niemann from the Research Center Borstel, Leibniz Lung Center was honored with the Gardner Middlebrook Lifetime Achievement Award. The award was presented online

Researchers from the German Center for Infection Research (DZIF) at Charité – Universitätsmedizin Berlin and the University of Bonn have examined the way in which SARS-CoV-2 reprograms the metabolism

SARS-CoV-2 infection causes severe inflammation of the lungs and other vital organs. Why some infected individuals respond with an exaggerated immune response to the virus remains not well understood

There is still an urgent need for drugs against the new coronavirus. This urgency increases further with the emergence of new virus mutations that could push vaccines to their limits. For more than a

What started as the preliminary analysis of routine laboratory data has since evolved into the largest-ever study of viral load levels in patients with SARS-CoV-2. A team of researchers from the

An international research team, led by scientists from Tübingen and the German Center for Infection Research (DZIF) discovers additional component in staphylococcal cell wall that turns the bacterium

At the University Hospital of Tübingen, a clinical trial led by Prof. Dr. Peter Kremsner, Director of the Institute of Tropical Medicine, Travel Medicine and Human Parasitology and Dr. Rolf Fendel

In addition to the SARS coronavirus-2 that is currently prevalent worldwide, scientists continue to keep an eye on the related MERS coronavirus, as it, too, could potentially become a supra-regional